PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Cancer Treatment and Your Heart: The Hidden Side Effect Every Patient Should Understand.
For many people diagnosed with cancer, the biggest fears are obvious—losing their hair, feeling nauseated, or enduring months of chemotherapy. Few patients are told that one of the most important organs affected by cancer treatment may be the heart.
As someone who has lived through cancer treatment and spent decades researching evidence-based integrative therapies, I’ve learned that surviving cancer is only part of the journey. Living well afterward means protecting every organ that helped you survive—including your heart.
I was diagnosed with chemotherapy-induced cardiomyopathy almost 15 years to the day after I completed my autologous stem cell transplant. During the previous months, I had undergone adriamycin, cytoxan, busulphan, and melphalan. All known cardiotoxic chemotherapy regimens. Looking back, I’m surprised that it took me 15 years to realize my heart damage.
Full transparency: I’m more likely to die of heart problems than I am of my cancer at this point in my cancer survival.
The encouraging news? While many cancer treatments can affect cardiovascular health, there is much more we know today about preventing, detecting, and managing these complications than ever before. Cardio-oncology has come a long way since my cancer treatments in 1995.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about cancer treatment and your heart.
Good luck,
Cancer therapies are designed to destroy rapidly dividing cancer cells. Unfortunately, some treatments also affect healthy tissues, including:
Some damage occurs during treatment. Other complications develop slowly over years or even decades.
As cancer survival improves, cardiovascular disease has become one of the leading long-term health concerns for cancer survivors.
| Cancer Treatment | Potential Cardiovascular Effects |
|---|---|
| Anthracycline chemotherapy (doxorubicin, daunorubicin) | Cardiomyopathy, heart failure |
| HER2-targeted therapy (trastuzumab) | Reduced heart pumping function |
| Immune checkpoint inhibitors (Keytruda, Opdivo, Yervoy) | Myocarditis, arrhythmias |
| VEGF inhibitors (bevacizumab and others) | Hypertension, heart failure, blood clots |
| Tyrosine kinase inhibitors | High blood pressure, arrhythmias, QT prolongation |
| Chest radiation therapy | Coronary artery disease, valve disease, pericardial disease, fibrosis |
| CAR-T cell therapy | Acute cardiovascular complications during treatment |
Not everyone experiences these problems. However, understanding the risks allows patients and physicians to monitor for complications before permanent damage develops.
Today’s cancer treatments are helping more people survive than ever before.
That success has created a new challenge.
Many survivors now live long enough to develop treatment-related heart disease years after finishing therapy.
Researchers estimate that cardiovascular disease is now one of the leading non-cancer causes of death among long-term cancer survivors.
The goal of modern oncology is no longer simply curing cancer—it is helping patients live long, healthy lives afterward.
Some patients have a higher likelihood of developing cardiovascular complications.
Risk factors include:
Having one or more of these risk factors does not mean heart damage is inevitable. It means closer monitoring may be appropriate.
Heart problems often begin gradually.
Contact your healthcare provider if you develop:
Early evaluation often leads to better outcomes.
Fortunately, oncology and cardiology have developed several strategies to reduce cardiovascular complications.
These include:
Before starting certain cancer treatments, your physician may recommend:
These establish a baseline so future changes can be detected early.
Many cancer centers now have dedicated cardio-oncology clinics where cardiologists and oncologists work together to protect heart function before, during, and after treatment.
Depending on your individual situation, physicians may recommend:
These medications are not appropriate for everyone but may reduce risk in higher-risk patients.
One of the strengths of integrative oncology is recognizing that lifestyle choices influence cardiovascular health throughout cancer treatment and survivorship.
Regular physical activity is among the most powerful heart-protective interventions available.
Research consistently shows that appropriately prescribed exercise may:
Even walking 20–30 minutes most days can provide meaningful benefits for many patients.
A Mediterranean dietary pattern emphasizes:
This eating pattern has been associated with reduced inflammation and improved cardiovascular health and may complement conventional cancer care.
High blood pressure accelerates cardiovascular damage.
Simple habits that help include:
Sleep supports:
Aim for 7–9 hours of quality sleep whenever possible.
Smoking substantially increases cardiovascular complications while also reducing treatment effectiveness for many cancers.
If you smoke, quitting remains one of the most beneficial steps you can take.
Chronic stress affects:
Helpful approaches include:
Some supplements have encouraging evidence for supporting cardiovascular health. However, they should always be discussed with your oncology team because interactions with treatment are possible.
| Supplement | Evidence Rating* | Comments |
|---|---|---|
| Coenzyme Q10 (CoQ10) | Moderate | Supports mitochondrial energy production; promising but larger cancer-specific trials are needed. |
| Omega-3 fatty acids | Moderate | May improve cardiovascular health and reduce triglycerides. |
| Magnesium | Moderate | Helpful when deficiency is present; may support normal heart rhythm. |
| Vitamin D | Moderate | Correcting deficiency supports bone and cardiovascular health. |
| Curcumin | Emerging | Anti-inflammatory effects are promising, but more clinical research is needed in cardio-oncology. |
PeopleBeatingCancer Evidence Rating
Strong: Multiple high-quality human clinical trials or guideline-supported evidence.
Moderate: Good human evidence, but additional studies are needed.
Emerging: Early human or strong preclinical evidence; promising but not yet definitive.
Insufficient: Limited or conflicting evidence.
Consider discussing these questions before beginning therapy:
✅ Cancer treatments can affect the heart in different ways depending on the therapy.
✅ Heart complications may appear during treatment—or years later.
✅ Early monitoring allows problems to be detected before they become serious.
✅ Regular exercise, a heart-healthy diet, blood pressure control, adequate sleep, and smoking cessation remain some of the most effective evidence-based ways to reduce cardiovascular risk.
✅ Cancer survivorship should include protecting your heart—not just preventing cancer recurrence.
Chemotherapy Preparation-
Cardiotoxicity-related side effects
Treatment Side Effects
Post Treatment-